Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Michl

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Endourology|March 22, 2008
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sumPierre I Karakiewicz, Felix K-H Chun, Andrea Gallina, et al.
The Journal of Urology|September 9, 2014
Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomyUwe Michl, Frederike Molfenter, Markus Graefen, et al.
The Journal of Urology|February 13, 2014
A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomyMeike Adam, Amir Hannah, Lars Budäus, et al.
Urologic Oncology|May 4, 2019
Prostate cancer prognosis in men with other malignancies prior to radical prostatectomyPeter Klippenstein, Thorsten Schlomm, Gunhild von Amsberg, et al.
European Urology|August 17, 2015
Nerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical ProstatectomyUwe Michl, Pierre Tennstedt, Lena Feldmeier, et al.
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Urologic Oncology|May 12, 2015
Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibilityJonas Schiffmann, Philipp Wenzel, Georg Salomon, et al.
Prostate Cancer and Prostatic Diseases|June 11, 2024
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experienceFrancesca Ambrosini, Felix Preisser, Derya Tilki, et al.
Experimental and Molecular Pathology|August 17, 2013
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyKatharina Grupp, Thorsten Simon Höhne, Kristina Prien, et al.
International Journal of Cancer|May 27, 2015
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerMartina Kluth, Frederic Runte, Philipp Barow, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Endourology|March 22, 2008
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sumPierre I Karakiewicz, Felix K-H Chun, Andrea Gallina, et al.
The Journal of Urology|September 9, 2014
Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomyUwe Michl, Frederike Molfenter, Markus Graefen, et al.
The Journal of Urology|February 13, 2014
A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomyMeike Adam, Amir Hannah, Lars Budäus, et al.
Urologic Oncology|May 4, 2019
Prostate cancer prognosis in men with other malignancies prior to radical prostatectomyPeter Klippenstein, Thorsten Schlomm, Gunhild von Amsberg, et al.
European Urology|August 17, 2015
Nerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical ProstatectomyUwe Michl, Pierre Tennstedt, Lena Feldmeier, et al.
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Urologic Oncology|May 12, 2015
Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibilityJonas Schiffmann, Philipp Wenzel, Georg Salomon, et al.
Prostate Cancer and Prostatic Diseases|June 11, 2024
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experienceFrancesca Ambrosini, Felix Preisser, Derya Tilki, et al.
Experimental and Molecular Pathology|August 17, 2013
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyKatharina Grupp, Thorsten Simon Höhne, Kristina Prien, et al.
International Journal of Cancer|May 27, 2015
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerMartina Kluth, Frederic Runte, Philipp Barow, et al.
Pageof 7